Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Neuroprotective Effects of Kinin B2 Receptor in Organotypic Hippocampal Cultures of Middle-Aged Mice.

Toricelli M, Evangelista SR, Oliveira LR, Viel TA, Buck HS.

Front Aging Neurosci. 2019 Jul 12;11:168. doi: 10.3389/fnagi.2019.00168. eCollection 2019.

2.

α7 nicotinic ACh receptors are necessary for memory recovery and neuroprotection promoted by attention training in amyloid-β-infused mice.

Telles-Longui M, Mourelle D, Schöwe NM, Cipolli GC, Malerba HN, Buck HS, Viel TA.

Br J Pharmacol. 2019 Sep;176(17):3193-3205. doi: 10.1111/bph.14744. Epub 2019 Jul 14.

PMID:
31144293
3.

Enriched Environment Significantly Reduced Senile Plaques in a Transgenic Mice Model of Alzheimer's Disease, Improving Memory.

Balthazar J, Schöwe NM, Cipolli GC, Buck HS, Viel TA.

Front Aging Neurosci. 2018 Sep 26;10:288. doi: 10.3389/fnagi.2018.00288. eCollection 2018.

4.

Performance evaluation of the PET component of a hybrid PET/CT-ultrafast ultrasound imaging instrument.

Perez-Liva M, Viel T, Yoganathan T, Garofalakis A, Sourdon J, Facchin C, Tanter M, Provost J, Tavitian B.

Phys Med Biol. 2018 Sep 21;63(19):19NT01. doi: 10.1088/1361-6560/aad946.

PMID:
30091723
5.

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.

Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, Sovran B, Denis RGP, Dairou J, Cardellini M, Moreno-Navarrete JM, Straub M, Jegou S, McQuitty C, Viel T, Esposito B, Tavitian B, Callebert J, Luquet SH, Federici M, Fernandez-Real JM, Burcelin R, Launay JM, Tedgui A, Mallat Z, Sokol H, Taleb S.

Nat Med. 2018 Aug;24(8):1113-1120. doi: 10.1038/s41591-018-0060-4. Epub 2018 Jun 25.

PMID:
29942089
6.

Simultaneous positron emission tomography and ultrafast ultrasound for hybrid molecular, anatomical and functional imaging.

Provost J, Garofalakis A, Sourdon J, Bouda D, Berthon B, Viel T, Perez-Liva M, Lussey-Lepoutre C, Favier J, Correia M, Pernot M, Chiche J, Pouysségur J, Tanter M, Tavitian B.

Nat Biomed Eng. 2018 Feb;2(2):85-94. doi: 10.1038/s41551-018-0188-z. Epub 2018 Feb 6.

PMID:
31015628
7.

Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis.

Krzywinska E, Kantari-Mimoun C, Kerdiles Y, Sobecki M, Isagawa T, Gotthardt D, Castells M, Haubold J, Millien C, Viel T, Tavitian B, Takeda N, Fandrey J, Vivier E, Sexl V, Stockmann C.

Nat Commun. 2017 Nov 17;8(1):1597. doi: 10.1038/s41467-017-01599-w.

8.

Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor Antagonism.

Sourdon J, Lager F, Viel T, Balvay D, Moorhouse R, Bennana E, Renault G, Tharaux PL, Dhaun N, Tavitian B.

Theranostics. 2017 Jul 8;7(11):2757-2774. doi: 10.7150/thno.19551. eCollection 2017.

9.

Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.

Laukamp KR, Lindemann F, Weckesser M, Hesselmann V, Ligges S, Wölfer J, Jeibmann A, Zinnhardt B, Viel T, Schäfers M, Paulus W, Stummer W, Schober O, Jacobs AH.

Mol Imaging. 2017 Jan 1;16:1536012116687651. doi: 10.1177/1536012116687651.

10.

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection.

Perrod G, Pidial L, Camilleri S, Bellucci A, Casanova A, Viel T, Tavitian B, Cellier C, Clément O, Rahmi G.

J Vis Exp. 2017 Feb 10;(120). doi: 10.3791/55018.

11.

In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease.

Fricke IB, Schelhaas S, Zinnhardt B, Viel T, Hermann S, Couillard-Després S, Jacobs AH.

Eur J Neurosci. 2017 Apr;45(7):975-986. doi: 10.1111/ejn.13540. Epub 2017 Mar 7.

PMID:
28194885
12.

Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake.

Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH.

Cancer Res. 2017 Apr 15;77(8):1831-1841. doi: 10.1158/0008-5472.CAN-16-2628. Epub 2017 Jan 30.

13.

Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis.

Schmitt CC, Aranias T, Viel T, Chateau D, Le Gall M, Waligora-Dupriet AJ, Melchior C, Rouxel O, Kapel N, Gourcerol G, Tavitian B, Lehuen A, Brot-Laroche E, Leturque A, Serradas P, Grosfeld A.

Mol Metab. 2016 Nov 4;6(1):61-72. doi: 10.1016/j.molmet.2016.10.008. eCollection 2017 Jan.

14.

Preclinical Evidence That 3'-Deoxy-3'-[18F]Fluorothymidine PET Can Visualize Recovery of Hematopoiesis after Gemcitabine Chemotherapy.

Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs AH.

Cancer Res. 2016 Dec 15;76(24):7089-7095. Epub 2016 Oct 20.

15.

Neuroprotective Effects of Pomegranate Peel Extract after Chronic Infusion with Amyloid-β Peptide in Mice.

Morzelle MC, Salgado JM, Telles M, Mourelle D, Bachiega P, Buck HS, Viel TA.

PLoS One. 2016 Nov 9;11(11):e0166123. doi: 10.1371/journal.pone.0166123. eCollection 2016.

16.

Imaging Reactive Oxygen Species-Induced Modifications in Living Systems.

Maulucci G, Bačić G, Bridal L, Schmidt HH, Tavitian B, Viel T, Utsumi H, Yalçın AS, De Spirito M.

Antioxid Redox Signal. 2016 Jun 1;24(16):939-58. doi: 10.1089/ars.2015.6415. Review.

17.

Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.

O'Halloran PJ, Viel T, Murray DW, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek MA, Dicker P, Hermann S, Faber C, Klasen T, Schäfers M, O'Brien D, Prehn JH, Jacobs AH, Byrne AT.

Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1673-83. doi: 10.1007/s00259-016-3343-3. Epub 2016 Mar 15.

PMID:
26975402
18.

6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.

Fricke IB, Viel T, Worlitzer MM, Collmann FM, Vrachimis A, Faust A, Wachsmuth L, Faber C, Dollé F, Kuhlmann MT, Schäfers K, Hermann S, Schwamborn JC, Jacobs AH.

Eur J Neurosci. 2016 May;43(10):1352-65. doi: 10.1111/ejn.13232. Epub 2016 Apr 5.

PMID:
26950181
19.

Cell Sheet Transplantation for Esophageal Stricture Prevention after Endoscopic Submucosal Dissection in a Porcine Model.

Perrod G, Rahmi G, Pidial L, Camilleri S, Bellucci A, Casanova A, Viel T, Tavitian B, Cellier C, Clement O.

PLoS One. 2016 Mar 1;11(3):e0148249. doi: 10.1371/journal.pone.0148249. eCollection 2016.

20.

Dataset for the role of sustained attention in memory formation of transgenic mice for Alzheimer׳s disease.

Schöwe NM, de Oliveira EM, Buck HS, Viel TA.

Data Brief. 2016 Jan 16;6:763-8. doi: 10.1016/j.dib.2016.01.015. eCollection 2016 Mar.

21.

Highlight: Kinin 2015 at São Paulo, Brazil.

Buck HS, Calixto JB, Pesquero JB, Campos MM, Viel TA, Costa-Neto CM.

Biol Chem. 2016 Apr;397(4):281-2. doi: 10.1515/hsz-2016-0115. No abstract available.

PMID:
26841447
22.

Correction: Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.

Nunes MA, Schöwe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, Souza SI, Balthazar J, Albuquerque MS, Caetano AL, Viel TA, Buck HS.

PLoS One. 2015 Dec 17;10(12):e0145695. doi: 10.1371/journal.pone.0145695. eCollection 2015. No abstract available.

23.

Kinin B1 receptor mediates memory impairment in the rat hippocampus.

Dong-Creste KE, Baraldi-Tornisielo T, Caetano AL, Gobeil F, Montor WR, Viel TA, Buck HS.

Biol Chem. 2016 Apr;397(4):353-64. doi: 10.1515/hsz-2015-0235.

PMID:
26669247
24.

Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.

Nunes MA, Schöwe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, Souza SI, Balthazar J, Albuquerque MS, Caetano AL, Viel TA, Buck HS.

PLoS One. 2015 Nov 25;10(11):e0142267. doi: 10.1371/journal.pone.0142267. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0145695.

25.

Kinin B2 receptor can play a neuroprotective role in Alzheimer's disease.

Caetano AL, Dong-Creste KE, Amaral FA, Monteiro-Silva KC, Pesquero JB, Araujo MS, Montor WR, Viel TA, Buck HS.

Neuropeptides. 2015 Oct;53:51-62. doi: 10.1016/j.npep.2015.09.001. Epub 2015 Sep 19.

PMID:
26387425
26.

Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke.

Zinnhardt B, Viel T, Wachsmuth L, Vrachimis A, Wagner S, Breyholz HJ, Faust A, Hermann S, Kopka K, Faber C, Dollé F, Pappata S, Planas AM, Tavitian B, Schäfers M, Sorokin LM, Kuhlmann MT, Jacobs AH.

J Cereb Blood Flow Metab. 2015 Nov;35(11):1711-21. doi: 10.1038/jcbfm.2015.149. Epub 2015 Jul 1.

27.

Altered KLOTHO and NF-κB-TNF-α Signaling Are Correlated with Nephrectomy-Induced Cognitive Impairment in Rats.

Degaspari S, Tzanno-Martins CB, Fujihara CK, Zatz R, Branco-Martins JP, Viel TA, Buck Hde S, Orellana AM, Böhmer AE, Lima Lde S, Andreotti DZ, Munhoz CD, Scavone C, Kawamoto EM.

PLoS One. 2015 May 11;10(5):e0125271. doi: 10.1371/journal.pone.0125271. eCollection 2015.

28.

Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment.

Vasconcelos AR, Yshii LM, Viel TA, Buck HS, Mattson MP, Scavone C, Kawamoto EM.

J Neuroinflammation. 2014 May 6;11:85. doi: 10.1186/1742-2094-11-85.

29.

Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.

Schelhaas S, Wachsmuth L, Viel T, Honess DJ, Heinzmann K, Smith DM, Hermann S, Wagner S, Kuhlmann MT, Müller-Tidow C, Kopka K, Schober O, Schäfers M, Schneider R, Aboagye EO, Griffiths J, Faber C, Jacobs AH.

J Nucl Med. 2014 Jun;55(6):983-8. doi: 10.2967/jnumed.113.133348. Epub 2014 Apr 28.

30.

Is radiographic measurement of distal femoral torsion reliable?

Viel T, Casin C, Ducellier F, Steiger V, Bigorre N, Bizot P.

Orthop Traumatol Surg Res. 2013 Sep;99(5):517-22. doi: 10.1016/j.otsr.2013.02.009. Epub 2013 Jul 29.

31.

Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.

Viel T, Schelhaas S, Wagner S, Wachsmuth L, Schwegmann K, Kuhlmann M, Faber C, Kopka K, Schäfers M, Jacobs AH.

PLoS One. 2013 Jul 4;8(7):e67911. doi: 10.1371/journal.pone.0067911. Print 2013.

32.

Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI.

Viel T, Boehm-Sturm P, Rapic S, Monfared P, Neumaier B, Hoehn M, Jacobs AH.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1595-606. doi: 10.1007/s00259-013-2464-1. Epub 2013 Jun 11.

PMID:
23754761
34.

Cognitive stimulation during lifetime and in the aged phase improved spatial memory, and altered neuroplasticity and cholinergic markers of mice.

Baraldi T, Schöwe NM, Balthazar J, Monteiro-Silva KC, Albuquerque MS, Buck HS, Viel TA.

Exp Gerontol. 2013 Aug;48(8):831-8. doi: 10.1016/j.exger.2013.05.055. Epub 2013 May 23.

PMID:
23707230
35.

A systemic transcriptome analysis reveals the regulation of neural stem cell maintenance by an E2F1-miRNA feedback loop.

Palm T, Hemmer K, Winter J, Fricke IB, Tarbashevich K, Sadeghi Shakib F, Rudolph IM, Hillje AL, De Luca P, Bahnassawy L, Madel R, Viel T, De Siervi A, Jacobs AH, Diederichs S, Schwamborn JC.

Nucleic Acids Res. 2013 Apr 1;41(6):3699-712. doi: 10.1093/nar/gkt070. Epub 2013 Feb 8.

36.

Behavioral changes in Rattus norvegicus coinfected by Toxocara canis and Toxoplasma gondii.

Queiroz ML, Viel TA, Papa CH, Lescano SA, Chieffi PP.

Rev Inst Med Trop Sao Paulo. 2013 Jan-Feb;55(1):51-3.

37.

Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technology.

Viel T, Monfared P, Schelhaas S, Fricke IB, Kuhlmann MT, Fraefel C, Jacobs AH.

Mol Ther. 2013 Mar;21(3):570-9. doi: 10.1038/mt.2012.278. Epub 2013 Jan 15.

38.

Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease.

Nunes MA, Viel TA, Buck HS.

Curr Alzheimer Res. 2013 Jan;10(1):104-7.

PMID:
22746245
39.

Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.

Viel T, Talasila KM, Monfared P, Wang J, Jikeli JF, Waerzeggers Y, Neumaier B, Backes H, Brekka N, Thorsen F, Stieber D, Niclou SP, Winkeler A, Tavitian B, Hoehn M, Bjerkvig R, Miletic H, Jacobs AH.

J Nucl Med. 2012 Jul;53(7):1135-45. doi: 10.2967/jnumed.111.101659. Epub 2012 Jun 11.

40.

Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease.

Rapic S, Backes H, Viel T, Kummer MP, Monfared P, Neumaier B, Vollmar S, Hoehn M, Van der Linden A, Heneka MT, Jacobs AH.

Neurobiol Aging. 2013 Jan;34(1):351-4. doi: 10.1016/j.neurobiolaging.2012.04.016. Epub 2012 May 30.

PMID:
22651996
41.

Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Waerzeggers Y, Ullrich RT, Monfared P, Viel T, Weckesser M, Stummer W, Schober O, Winkeler A, Jacobs AH.

Br J Radiol. 2011 Dec;84 Spec No 2:S179-95. doi: 10.1259/bjr/76389842. Review.

42.

Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.

Waerzeggers Y, Monfared P, Viel T, Faust A, Kopka K, Schäfers M, Tavitian B, Winkeler A, Jacobs A.

Br J Radiol. 2011 Dec;84 Spec No 2:S168-78. doi: 10.1259/bjr/66405626. Review.

43.

Chronic infusion of amyloid-β peptide and sustained attention altered α7 nicotinic receptor density in the rat brain.

Viel TA, Caetano AL, Albuquerque MS, Araujo MS, Buck HS.

Curr Alzheimer Res. 2012 Dec;9(10):1210-20.

PMID:
22515492
44.

The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience.

Puls M, Viel T, Danner BC, Jacobshagen C, Teucher N, Hanekop G, Schöndube F, Hasenfuss G, Seipelt RG, Schillinger W.

Clin Res Cardiol. 2012 Jul;101(7):553-63. doi: 10.1007/s00392-012-0426-4. Epub 2012 Feb 21.

45.

The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.

Winkeler A, Boisgard R, Awde AR, Dubois A, Thézé B, Zheng J, Ciobanu L, Dollé F, Viel T, Jacobs AH, Tavitian B.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):811-23. doi: 10.1007/s00259-011-2041-4. Epub 2012 Jan 21.

46.

Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo.

Viel TA, Buck HS.

Curr Alzheimer Res. 2011 Feb;8(1):59-66. Review.

PMID:
21143155
47.

Influence of anabolic steroid treatment associated to physical exercise in the ultrasonic vocalization of rats.

Bittencourt MF, Dong KE, Caetano AL, Viel TA, Andrada e Silva MA, Buck HS.

J Acoust Soc Am. 2010 Nov;128(5):2949-54. doi: 10.1121/1.3488350.

PMID:
21110590
48.

Change in central kinin B2 receptor density after exercise training in rats.

Caetano AL, Viel TA, Bittencourt MF, Araujo MS, De Angelis K, Buck HS.

Auton Neurosci. 2010 Dec 8;158(1-2):71-8. doi: 10.1016/j.autneu.2010.06.013. Epub 2010 Jul 15.

PMID:
20637711
49.

Mouse models in neurological disorders: applications of non-invasive imaging.

Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH.

Biochim Biophys Acta. 2010 Oct;1802(10):819-39. doi: 10.1016/j.bbadis.2010.04.009. Epub 2010 May 13. Review.

50.

In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C]PK11195 in an acute rodent model.

Van Camp N, Boisgard R, Kuhnast B, Thézé B, Viel T, Grégoire MC, Chauveau F, Boutin H, Katsifis A, Dollé F, Tavitian B.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):962-72. doi: 10.1007/s00259-009-1353-0. Epub 2010 Jan 13.

PMID:
20069292

Supplemental Content

Support Center